COX15
Heme A synthase COX15
Also known as: CEMCOX2, COX15_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7KZN9
- Gene
- COX15
- Ensembl
- ENSG00000014919
- Chromosome
- 10
- Canonical length
- 410 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
Cytochrome c oxidase (COX), the terminal component of the mitochondrial respiratory chain, catalyzes the electron transfer from reduced cytochrome c to oxygen. This component is a heteromeric complex consisting of 3 catalytic subunits encoded by mitochondrial genes and multiple structural subunits encoded by nuclear genes. The mitochondrially-encoded subunits function in electron transfer, and the nuclear-encoded subunits may function in the regulation and assembly of the complex. This nuclear gene encodes a protein which is not a structural subunit, but may be essential for the biogenesis of COX formation and may function in the hydroxylation of heme O, according to the yeast mutant studies. This protein is predicted to contain 5 transmembrane domains localized in the mitochondrial inner membrane. Alternative splicing of this gene generates two transcript variants diverging in the 3' region. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
410 residues, UniProt reviewed canonical sequence.
>Q7KZN9|COX15
1 MQRLLFPPLR ALKGRQYLPL LAPRAAPRAQ CDCIRRPLRP GQYSTISEVA LQSGRGTVSL
61 PSKAAERVVG RWLLVCSGTV AGAVILGGVT RLTESGLSMV DWHLIKEMKP PTSQEEWEAE
121 FQRYQQFPEF KILNHDMTLT EFKFIWYMEY SHRMWGRLVG LVYILPAAYF WRKGWLSRGM
181 KGRVLALCGL VCFQGLLGWY MVKSGLEEKS DSHDIPRVSQ YRLAAHLGSA LVLYCASLWT
241 SLSLLLPPHK LPETHQLLQL RRFAHGTAGL VFLTALSGAF VAGLDAGLVY NSFPKMGESW
301 IPEDLFTFSP ILRNVFENPT MVQFDHRILG ITSVTAITVL YFLSRRIPLP RRTKMAAVTL
361 LALAYTQVGL GISTLLMYVP TPLAATHQSG SLALLTGALW LMNELRRVPKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against COX15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 8
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- tongue: 25 nTPM
- skeletal muscle: 25 nTPM
- liver: 22 nTPM
- kidney: 20 nTPM
- adrenal gland: 19 nTPM
- choroid plexus: 16 nTPM
Single-cell type
- distal convoluted tubule cells: 29 nCPM
- renal collecting duct intercalated cells: 26 nCPM
- renal collecting duct principal cells: 26 nCPM
- podocytes: 25 nCPM
- papillary tip epithelial cells: 24 nCPM
- loop of henle epithelial cells: 23 nCPM
Immune cell
- basophil: 20 nTPM
- non-classical monocyte: 19 nTPM
- intermediate monocyte: 15 nTPM
- myeloid DC: 14 nTPM
- classical monocyte: 13 nTPM
- memory B-cell: 13 nTPM
Brain region
- choroid plexus: 23 nTPM
- white matter: 22 nTPM
- thalamus: 22 nTPM
- cerebral cortex: 21 nTPM
- basal ganglia: 21 nTPM
- midbrain: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about COX15.
Disease | AllUniProt
Conditions COX15 is implicated in, by any mechanism.
- Mitochondrial complex IV deficiency, nuclear type 6 (MC4DN6) MIM:615119
Disease | GeneticClinVar
44 pathogenic / likely-pathogenic of 505 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2
- Leigh syndrome
- Inborn genetic diseases
- See cases
- COX15-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.33
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.26
- DepMap mean gene effect
- -0.3
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- heme binding
- metal ion binding
- oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor
- heme A synthase activity
- oxidoreductase activity, acting on the CH-CH group of donors
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase S1, PA clan
- COX15/CtaA family
- Heme A synthase, type 2
- Cytochrome oxidase assembly protein
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads COX15 as an antibody target. Whether an autoantibody or antibody against COX15 could matter depends on whether native COX15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
COX15 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label COX15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...